The study was led by Dr Helda Tutunchi of Tabriz University of Medical Sciences in Iran, together with colleagues, and takes the form of a systematic review and meta-analysis, the highest tier of evidence synthesis in medical research. Rather than relying on any single trial, the team systematically combined and re-analysed the results of all available randomised controlled trials testing wholegrain intake against cardiovascular risk factors. The trials included in the analysis were conducted across Asia, Europe, the United States, Canada, Australia and Brazil, giving the findings a broad geographic and dietary-cultural span that strengthens their generalisability.

The motivation for the work, Dr Tutunchi explained, stems from a long-standing tension in the nutrition literature. Population studies, known as observational research, have consistently linked higher wholegrain intake with better heart health, but individual clinical trials have produced mixed findings, leaving clinicians and guideline writers without a clear target. “Although higher wholegrain intake has long been linked to better heart health in population studies, clinical trials have produced mixed findings,” she said. “This left an important practical question unanswered: how much whole grain should people eat to meaningfully improve cardiovascular health?” By pooling every eligible randomised trial, the researchers aimed to resolve that uncertainty with numbers rather than impressions.

The results were striking in their breadth. Eating more wholegrain food reduced participants’ body weight and waist circumference, lowered both systolic and diastolic blood pressure, and improved blood lipid profiles, including reductions in total cholesterol, low-density lipoprotein cholesterol, often called LDL or “bad” cholesterol, and triglycerides. The analysis also documented reductions in fasting glucose and in interleukin-6, an inflammatory signalling molecule that is increasingly recognised as a contributor to atherosclerosis, the process underlying heart attacks and strokes. Importantly, the researchers graded the quality of the underlying evidence and found high-certainty support for improvements in body weight, waist circumference, total cholesterol and interleukin-6, with moderate-certainty evidence for benefits to LDL cholesterol, triglycerides, systolic blood pressure, fasting plasma glucose and insulin resistance as measured by the HOMA-IR index.

Perhaps the most actionable finding concerns dose. Benefits began to appear at intakes of around 30 to 40 grams of wholegrain per day, measured as dry weight, but the greatest improvements were seen at 60 to 100 grams per day, which corresponds to roughly four to six daily servings. The researchers illustrate what that looks like in practice: a bowl of oatmeal at breakfast, a sandwich made with wholegrain bread at lunch, and a serving of brown rice at dinner would together place a person squarely within the optimal range. This dose-response analysis is what distinguishes the new work from previous reviews, which typically asked whether wholegrains help without quantifying how much is needed.

Dr Tutunchi described the analysis as the largest and most comprehensive of its kind, but she was careful to spell out its limitations. Most of the included trials were relatively short, averaging about eight weeks in duration, which means the researchers cannot determine whether the observed benefits are maintained over years rather than weeks. In addition, relatively few studies evaluated very high intakes above 140 grams per day, leaving the effects at those levels uncertain. Crucially, none of the included trials assessed cardiovascular events such as heart attacks or strokes directly; they measured risk factors instead. Longer-term studies tracking actual disease outcomes will be needed to confirm that the improvements in risk markers translate into fewer cardiovascular events.

Despite those caveats, the researchers argue that the findings carry a clear practical message. “Increasing wholegrain intake is a relatively simple, accessible and affordable dietary strategy that can complement other lifestyle and medical interventions,” Dr Tutunchi said. She noted that the optimal intake of 60 to 100 grams per day sits toward the upper end of current dietary recommendations, so the results do not necessarily call for major changes to existing guidelines. Instead, they support public health strategies that help people move toward the higher end of current targets, encouraging swaps from refined grains to minimally processed wholegrain staples rather than dramatic dietary overhauls.

One of the study’s most conceptually important insights is that wholegrains appear to benefit cardiovascular health through several modest improvements acting together, rather than through one large effect on a single risk factor. The researchers observed parallel improvements across multiple physiological pathways, including blood lipids, blood pressure, glucose regulation, body fat and inflammatory markers. Although the change in any individual risk factor was generally modest, improving several risk factors simultaneously could compound into a substantially greater reduction in long-term cardiovascular risk. This multi-pathway model helps explain why single-marker trials may have appeared inconsistent: each trial may have captured only a fragment of the overall effect.

An accompanying editorial by Dr Cecilie Kyrø of the Danish Cancer Institute in Copenhagen and colleagues places the findings in a broader historical and scientific context. More than half a century ago, the surgeon Sir Denis Burkitt and colleagues proposed that the refining of staple carbohydrates, which strips out cereal fibre as whole grains are converted to refined grains, underpinned a broad spectrum of so-called Western diseases through effects on stool bulk, intestinal transit time and the colonic environment. Whole grains, by definition, retain all three main parts of the cereal kernel, the bran, germ and endosperm, in the same proportions as in the intact grain, whether consumed as whole kernels, flakes, or milled into flour for bread and other foods. The editorial authors highlight that the dose-response analyses provide quantitative evidence to inform food-based dietary guidelines, and note that evidence from research into other disease endpoints suggests the benefits of wholegrain foods extend substantially beyond cardiometabolic disease.

The editorial also frames the findings as a challenge for clinicians and policymakers alike. For clinicians, the message is described as reassuringly simple: encouraging patients to replace refined grain foods with minimally processed whole grains is likely to yield modest but meaningful improvements in body weight, waist circumference and blood lipids, perhaps particularly in individuals with type 2 diabetes. At the population level, even small shifts in these markers can translate into substantial reductions in cardiometabolic events. The current United States dietary guidelines recommend two to four servings of whole grains per day, and the trial evidence indicates that higher intakes than presently recommended in some guidelines may be optimal for cardiometabolic health. From a policy perspective, the editorial authors argue, the real challenge is to make minimally processed wholegrain staples accessible, affordable and culturally acceptable, while avoiding a drift toward ultra-processed products that merely add whole grains to otherwise highly processed formulations. In other words, the source of the grain matters as much as the quantity, and the public health opportunity lies in returning whole grains to the centre of the plate in their least processed form.

Subject of Research: The effect of wholegrain consumption on cardiovascular disease risk factors

Article Title: Four to six servings of wholegrain per day lowers risk factors for heart disease

Article References: Four to six servings of wholegrain per day lowers risk factors for heart disease. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: wholegrain, cardiovascular disease, meta-analysis, diet, cholesterol, blood pressure, European Heart Journal, nutrition, randomised controlled trials, inflammation, dietary guidelines, LDL cholesterol